ITGA5 and gastric cancer: Significant differences were observed between ITGA5 expression and prognosis in gastric cancer (OS HR = 2.4, 95% CI = 1.96 to 2.97, P < 1e-16; DFS HR = 2.69, 95% CI = 2.04 to 3.54, P = 2.2e-13) (Fig. 2e-f) and live cancer (OS HR = 1.73, 95% CI = 1.22 to 2.44, P = 0.0017; DFS HR = 1.23, 95% CI = 0.88 to 1.72, P = 0.23) patients (Fig. 2g-h).